SBC Medical Group Holdings Inc
SBCNasdaqCIK 1930313HealthcareFiscal year ends Dec 31
Reports and events: 86 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-08-1307:00 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001193125-26-347843 |
| 2026-08-1306:50 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-347825 |
| 2026-07-1417:00 ET | 8-K | 3.01 Delisting notice; 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001493152-26-033195 |
| 2026-05-2806:09 ET | DEF 14A | Proxy statementPeriod 2026-05-28 | 0001493152-26-025514 |
| 2026-05-2016:15 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001493152-26-024609 |
| 2026-05-1407:00 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001193125-26-222737 |
| 2026-05-1406:50 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-222720 |
| 2026-04-3017:21 ET | 10-K/A | Annual report, amendedPeriod 2025-12-31 | 0001493152-26-020748 |
| 2026-04-2320:48 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001493152-26-018603 |
| 2026-04-2121:07 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001493152-26-018402 |
| 2026-03-2707:31 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001193125-26-127557 |
| 2026-03-2706:50 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-013078 |
| 2026-03-1021:53 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001493152-26-009606 |
| 2026-01-0507:00 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-001488 |
| 2025-12-3106:39 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-25-029699 |
| 2025-12-1506:01 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-318331 |
| 2025-11-1407:00 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001193125-25-281466 |
| 2025-11-1406:50 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-281439 |
| 2025-11-1306:02 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-278669 |
| 2025-08-1307:11 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001641172-25-023322 |
| 2025-08-1307:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001641172-25-023321 |
| 2025-07-1708:05 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001641172-25-019984 |
| 2025-06-3006:07 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001641172-25-017031 |
| 2025-06-1816:01 ET | 8-K | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001641172-25-015572 |
| 2025-05-2806:07 ET | DEF 14A | Proxy statementPeriod 2025-05-28 | 0001641172-25-012581 |
| 2025-05-1509:00 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001641172-25-010567 |
| 2025-05-1509:00 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001641172-25-010565 |
| 2025-05-0908:33 ET | 10-K/A | Annual report, amendedPeriod 2024-12-31 | 0001641172-25-009366 |
| 2025-04-3016:22 ET | 10-K/A | Annual report, amendedPeriod 2024-12-31 | 0001641172-25-007813 |
| 2025-04-0216:15 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001641172-25-002370 |
| 2025-03-2809:12 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001641172-25-001062 |
| 2025-03-2807:45 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001641172-25-001050 |
| 2025-02-1806:01 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-25-007047 |
| 2024-12-2009:00 ET | 8-K | 7.01 Regulation FD disclosure | 0001493152-24-050895 |
| 2024-11-1316:30 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001493152-24-045154 |
| 2024-11-1316:30 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-24-045152 |
| 2024-10-0809:58 ET | S-1 | Registration statement | 0001213900-24-086109 |
| 2024-10-0121:00 ET | SC 13D/A | Ownership report, active investor, amended | 0001140361-24-042519 |
| 2024-09-2421:07 ET | SC 13D/A | Ownership report, active investor, amended | 0001140361-24-041791 |
| 2024-09-2309:02 ET | SC 13D/A | Ownership report, active investor, amended | 0001213900-24-080820 |
| 2024-09-2308:56 ET | SC 13D | Ownership report, active investor | 0001213900-24-080818 |
| 2024-09-2016:05 ET | 8-K | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 3.03 Change to security holders’ rights; 4.01 Change of auditor; 5.01 Change in control; 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 5.05 Item not in the standard list; 5.06 Item not in the standard list; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-24-080668 |
| 2024-09-1920:13 ET | SC 13D/A | Ownership report, active investor, amended | 0001140361-24-041494 |
| 2024-08-2906:05 ET | 8-K | 5.07 Shareholder vote results; 7.01 Regulation FD disclosure | 0001493152-24-034279 |
| 2024-08-2317:43 ET | 8-K | 7.01 Regulation FD disclosure | 0001493152-24-033614 |
| 2024-08-2021:00 ET | SC 13D/A | Ownership report, active investor, amended | 0001140361-24-037997 |
| 2024-08-1616:15 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001213900-24-070251 |
| 2024-08-1209:08 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001493152-24-031176 |
| 2024-07-2621:02 ET | SC 13D/A | Ownership report, active investor, amended | 0001140361-24-034470 |
| 2024-05-2016:17 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001493152-24-020690 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:16 ET. Listed shows no prices and gives no investment advice.